PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Neolignans verrucosin and saucernetin reduced cell viability of DU145 cell lines at 100 μmol/L after 48h [PMID: 36752700]
Neolignans threo-austrobailignan-6 and verrucosin showed significant schistosomicidal activity against S. mansoni adult worms (EC50 12.6-28.1 μM) [PMID: 36369516]
Tetrahydrofuran dineolignans threo,threo-manassantin A and threo,erythro-manassantin A displayed activity against L. amazonensis promastigotes and amastigotes [PMID: 31595517]
Threo-austrobailignan-6 and threo-dihydroguaiaretic acid showed activity against T. cruzi trypomastigotes and amastigotes [PMID: 31271783]
Methanolic extract showed potent cytotoxicity against human CL-18 and MDA-MB-231 cell lines [PMID: 17352231]
Evidence summary
PubMed sources
- 1.PMID: 35825929 (1867) — Saururus Cernuus. · Atlanta medical and surgical journal
- 2.PMID: 36752700 (2023) — Cytotoxic effects of neolignans from Saururus cernuus (Saururaceae) against prostate cancer cells. · Chemical biology & drug design
- 3.PMID: 36369516 (2022) — Neolignans isolated from Saururus cernuus L. (Saururaceae) exhibit efficacy against Schistosoma mansoni. · Scientific reports
- 4.PMID: 2161446 (1990) — Chemistry of Saururus cernuus, VI: Three new neolignans. · Journal of natural products
- 5.PMID: 31595517 (2019) — Antileishmanial activity and ultrastructural changes of related tetrahydrofuran dineolignans isolated from Saururus cernuus L. (Saururaceae).